Part of The Stem Cellar blog series on 10 years of iPSCs. This year, scientists are celebrating the 10-year anniversary of Shinya Yamanaka’s Nobel Prize winning discovery of induced pluripotent stem cells (iPSCs). These are cells that are very similar biologically to embryonic stem cells and can develop into any cell in the body. iPSCs … Continue reading Stem Cell Experts Discuss the Ethical Implications of Translating iPSCs to the Clinic
Features
Science and Improv: Spotlight on CIRM Bridges Scholar Jill Tsai
As part of our CIRM scholar series, we’re featuring the research and career accomplishments of CIRM funded students. What do science and improv have in common? The answer is not a whole lot. However, I recently met a talented student from our CIRM Bridges master’s program who one day is going to change this. Meet … Continue reading Science and Improv: Spotlight on CIRM Bridges Scholar Jill Tsai
CIRM Grantees Reflect on Ten Years of iPS Cells
For the fourth entry for our “Ten Years of Induced Pluripotent Stem (iPS) Cells” series, which we’ve been posting all month, I reached out to three of our CIRM grantees to get their perspectives on the impact of iPSC technology on their research and the regenerative medicine field as a whole: Step back in time … Continue reading CIRM Grantees Reflect on Ten Years of iPS Cells
Making a deposit in the Bank: using stem cells from children with rare diseases to find new treatments
Part of The Stem Cellar series on ten years of iPS cells For Chris Waters, the motivation behind her move from big pharmaceutical companies and biotech to starting a non-profit organization focused on rare diseases in children is simple: “What’s most important is empowering patient families and helping them accelerate research to the clinical solutions … Continue reading Making a deposit in the Bank: using stem cells from children with rare diseases to find new treatments
CIRM jumped on the iPS cell bandwagon before it had wheels
Part of The Stem Cellar series on ten years of iPS cells The first press release I issued that announced new research grants after arriving at CIRM in 2008 detailed 18 “New Cell Line” awards. Ten of those grants, announced in June that year, were for a type of stem cell that had not even … Continue reading CIRM jumped on the iPS cell bandwagon before it had wheels
Sneak Peak of our New Blog Series and the 10 Years of iPSCs Cell Symposium
New Blog Series A decade has passed since Dr. Shinya Yamanaka and his colleagues discovered the Nobel Prize-winning technology called induced pluripotent stem cells (iPSCs). These stem cells can be derived from adult tissue and can develop into any cell type in the body. They are an extremely useful tool to model disease in a … Continue reading Sneak Peak of our New Blog Series and the 10 Years of iPSCs Cell Symposium
Out of the mouths, or in this case hearts, of babes comes a hopeful therapy for heart attack patients
Lessons learned from babies with heart failure could now help adults Inspiration can sometimes come from the most unexpected of places. For English researcher Stephen Westaby it came from seeing babies who had heart attacks bounce back and recover. It led Westaby to a new line of research that could offer hope to people who … Continue reading Out of the mouths, or in this case hearts, of babes comes a hopeful therapy for heart attack patients
CIRM Scholar Jessica Gluck on using stem cells to make biological pacemakers for the heart
As part of our CIRM scholar series, we feature the research accomplishments of students and postdocs that have received CIRM funding. I’d like to introduce you to one of our CIRM Scholars, Jessica Gluck. She’s currently a Postdoctoral Fellow at UC Davis working on human stem cell models of heart development. Jessica began her education … Continue reading CIRM Scholar Jessica Gluck on using stem cells to make biological pacemakers for the heart
CIRM Scholar Spotlight: Berkeley’s Maroof Adil on stem cell transplants for Parkinson’s disease
Stem cell therapy has a lot of potential for Parkinson’s patients and the scientists that study it. One of our very own CIRM scholars, Maroof Adil, is making it his mission to develop stem cell based therapies to treat brain degenerating diseases like Parkinson’s. Maroof got his undergraduate degrees from MIT in both Chemical Engineering … Continue reading CIRM Scholar Spotlight: Berkeley’s Maroof Adil on stem cell transplants for Parkinson’s disease
CIRM Scholar Helen Fong on Stem Cells and Brain Disease
Meet another one of our talented CIRM Scholars, Helen Fong. She is currently a Research Scientist at the Gladstone Institutes and did her graduate work at the University of California, Irvine. Her passions include stem cells, disease modeling, and playing with differentiation protocols – the processes that tell stem cells to mature into specific tissues. … Continue reading CIRM Scholar Helen Fong on Stem Cells and Brain Disease
The Stem Cellar 